(Q33819518)

29 July 2017

1 reference

title

Moderate hyperhomocysteinemia and cardiovascular disease (English)

1 reference

29 July 2017

Tsai MY

1

1 reference

29 July 2017

publication date

1 January 2000

1 reference

29 July 2017

published in

Translational Research

1 reference

29 July 2017

volume

135

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

16-25

1 reference

Methionine metabolism in mammals

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Structure-based perspectives on B12-dependent enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Molecular and biochemical approaches in the identification of heterozygotes for homocystinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Hyperhomocysteinemia: an independent risk factor for vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Methionine loading test is necessary for detection of hyperhomocysteinemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Plasma homocysteine levels and mortality in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Homocysteine, vitamins, and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Homocysteine and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Relationship between homocysteine and thrombotic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

A common 844INS68 insertion variant in the cystathionine beta-synthase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Methylenetetrahydrofolate reductase gene and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Cystathionine beta-synthase mutations in homocystinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

High frequency (71%) of cystathionine β-synthase mutation G307S in Irish homocystinuria patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Defects in human methionine synthase in cblG patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Cloning, mapping and RNA analysis of the human methionine synthase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Human methionine synthase. cDNA cloning, gene localization, and expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Pyridoxine Effects on Cystathionine Synthase in Rat Liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Accumulation of homocyst(e)ine in vitamin B-6 deficiency: a model for the study of cystathionine beta-synthase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Homocysteinemia due to folate deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Prevalence of cobalamin deficiency in the Framingham elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Gender differences and other determinants of the rise in plasma homocysteine after L-methionine loading

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Plasma homocysteine and menopausal status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50--effect of smoking and extent of disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Net uptake of plasma homocysteine by the rat kidney in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

No net renal extraction of homocysteine in fasting humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Serum Folate and Risk of Fatal Coronary Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

The effect of a subnormal vitamin B-6 status on homocysteine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Homocysteine mediated endothelial cell toxicity and its amelioration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

The detection of heterozygotes for homocystinuria by oral loading with L-methionine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Biological chemistry of thiols in the vasculature and in vascular-related disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2800%2970016-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-2143(00)70016-3

1 reference

29 July 2017

1 reference